Frank J. Lane
Direttore/Membro del Consiglio presso ALBERT LABS INTERNATIONAL CORP.
Posizioni attive di Frank J. Lane
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CFN ENTERPRISES INC. | Corporate Officer/Principal | 01/06/2019 | - |
| ALBERT LABS INTERNATIONAL CORP. | Direttore/Membro del Consiglio | - | - |
| Cfn Media | Fondatore | 01/01/2013 | - |
| Presidente | 01/06/2019 | - | |
Albert Labs, Inc.
 Albert Labs, Inc. Medical/Nursing ServicesHealth Services Part of Albert Labs International Corp., Albert Labs, Inc. is a pharmaceutical company based in London, UK. The company provides Psychedelic Therapy for UK & Europe, accelerating access for those suffering most in society with mental health. Albert Labs is focused on natural drug development, delivering faster access to novel mental health therapies for unmet needs. The British company is committed to ensuring transparency in their business and supply chains, and will not tolerate modern slavery. The CEO of the company is Michael Raymont. Albert Labs was acquired by ME Resource Corp. on March 10, 2022 for $0.16 million. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Frank J. Lane
Formazione di Frank J. Lane
| Seattle University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Regno Unito | 2 |
| Canada | 2 |
Posizioni
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
| Founder | 1 |
Settori
| Technology Services | 2 |
| Consumer Services | 2 |
| Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| CFN ENTERPRISES INC. | Technology Services |
| ALBERT LABS INTERNATIONAL CORP. | Health Technology |
| Aziende private | 2 |
|---|---|
| Cfn Media | |
Albert Labs, Inc.
Albert Labs, Inc. Medical/Nursing ServicesHealth Services Part of Albert Labs International Corp., Albert Labs, Inc. is a pharmaceutical company based in London, UK. The company provides Psychedelic Therapy for UK & Europe, accelerating access for those suffering most in society with mental health. Albert Labs is focused on natural drug development, delivering faster access to novel mental health therapies for unmet needs. The British company is committed to ensuring transparency in their business and supply chains, and will not tolerate modern slavery. The CEO of the company is Michael Raymont. Albert Labs was acquired by ME Resource Corp. on March 10, 2022 for $0.16 million. | Health Services |
- Borsa valori
- Insiders
- Frank J. Lane
- Esperienza
